Global Paediatric Vaccine Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Paediatric Vaccine market size was valued at USD 22020 million in 2023 and is forecast to a readjusted size of USD 31530 million by 2030 with a CAGR of 5.3% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Paediatric Vaccine industry chain, the market status of Age (0-3) (Pneumococcal, Varicella), Age (3-12) (Pneumococcal, Varicella), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Paediatric Vaccine.
Regionally, the report analyzes the Paediatric Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Paediatric Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Paediatric Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Paediatric Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Pneumococcal, Varicella).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Paediatric Vaccine market.
Regional Analysis: The report involves examining the Paediatric Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Paediatric Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Paediatric Vaccine:
Company Analysis: Report covers individual Paediatric Vaccine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Paediatric Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age (0-3), Age (3-12)).
Technology Analysis: Report covers specific technologies relevant to Paediatric Vaccine. It assesses the current state, advancements, and potential future developments in Paediatric Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Paediatric Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Paediatric Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Paediatric Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Paediatric Vaccine, with revenue, gross margin and global market share of Paediatric Vaccine from 2019 to 2024.
Chapter 3, the Paediatric Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Paediatric Vaccine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Paediatric Vaccine.
Chapter 13, to describe Paediatric Vaccine research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Paediatric Vaccine industry chain, the market status of Age (0-3) (Pneumococcal, Varicella), Age (3-12) (Pneumococcal, Varicella), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Paediatric Vaccine.
Regionally, the report analyzes the Paediatric Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Paediatric Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Paediatric Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Paediatric Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Pneumococcal, Varicella).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Paediatric Vaccine market.
Regional Analysis: The report involves examining the Paediatric Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Paediatric Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Paediatric Vaccine:
Company Analysis: Report covers individual Paediatric Vaccine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Paediatric Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age (0-3), Age (3-12)).
Technology Analysis: Report covers specific technologies relevant to Paediatric Vaccine. It assesses the current state, advancements, and potential future developments in Paediatric Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Paediatric Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Paediatric Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Pneumococcal
- Varicella
- Combinations
- Poliovirus
- Hepatitis
- MMR
- Pediatric Hormones
- HIB
- Allergy and Respiratory vaccines
- Other Pediatric vaccines
- Age (0-3)
- Age (3-12)
- Age Above 12
- GlaxoSmithCline
- Merck
- Sanofi
- Bristol-Myers Squibb
- Abbott Laboratories
- Eli Lilly
- Pfizer
- F. Hoffmann-La Roche
- Novo Nordisk
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Paediatric Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Paediatric Vaccine, with revenue, gross margin and global market share of Paediatric Vaccine from 2019 to 2024.
Chapter 3, the Paediatric Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Paediatric Vaccine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Paediatric Vaccine.
Chapter 13, to describe Paediatric Vaccine research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Paediatric Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Paediatric Vaccine by Type
1.3.1 Overview: Global Paediatric Vaccine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Paediatric Vaccine Consumption Value Market Share by Type in 2023
1.3.3 Pneumococcal
1.3.4 Varicella
1.3.5 Combinations
1.3.6 Poliovirus
1.3.7 Hepatitis
1.3.8 MMR
1.3.9 Pediatric Hormones
1.3.10 HIB
1.3.11 Allergy and Respiratory vaccines
1.3.12 Other Pediatric vaccines
1.4 Global Paediatric Vaccine Market by Application
1.4.1 Overview: Global Paediatric Vaccine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age (0-3)
1.4.3 Age (3-12)
1.4.4 Age Above
1.5 Global Paediatric Vaccine Market Size & Forecast
1.6 Global Paediatric Vaccine Market Size and Forecast by Region
1.6.1 Global Paediatric Vaccine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Paediatric Vaccine Market Size by Region, (2019-2030)
1.6.3 North America Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.4 Europe Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.6 South America Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Paediatric Vaccine Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 GlaxoSmithCline
2.1.1 GlaxoSmithCline Details
2.1.2 GlaxoSmithCline Major Business
2.1.3 GlaxoSmithCline Paediatric Vaccine Product and Solutions
2.1.4 GlaxoSmithCline Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithCline Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Paediatric Vaccine Product and Solutions
2.2.4 Merck Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Paediatric Vaccine Product and Solutions
2.3.4 Sanofi Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Paediatric Vaccine Product and Solutions
2.4.4 Bristol-Myers Squibb Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Paediatric Vaccine Product and Solutions
2.5.4 Abbott Laboratories Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Abbott Laboratories Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Paediatric Vaccine Product and Solutions
2.6.4 Eli Lilly Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Paediatric Vaccine Product and Solutions
2.7.4 Pfizer Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business
2.8.3 F. Hoffmann-La Roche Paediatric Vaccine Product and Solutions
2.8.4 F. Hoffmann-La Roche Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Paediatric Vaccine Product and Solutions
2.9.4 Novo Nordisk Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novo Nordisk Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Paediatric Vaccine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Paediatric Vaccine by Company Revenue
3.2.2 Top 3 Paediatric Vaccine Players Market Share in 2023
3.2.3 Top 6 Paediatric Vaccine Players Market Share in 2023
3.3 Paediatric Vaccine Market: Overall Company Footprint Analysis
3.3.1 Paediatric Vaccine Market: Region Footprint
3.3.2 Paediatric Vaccine Market: Company Product Type Footprint
3.3.3 Paediatric Vaccine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Paediatric Vaccine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Paediatric Vaccine Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Paediatric Vaccine Consumption Value Market Share by Application (2019-2024)
5.2 Global Paediatric Vaccine Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Paediatric Vaccine Consumption Value by Type (2019-2030)
6.2 North America Paediatric Vaccine Consumption Value by Application (2019-2030)
6.3 North America Paediatric Vaccine Market Size by Country
6.3.1 North America Paediatric Vaccine Consumption Value by Country (2019-2030)
6.3.2 United States Paediatric Vaccine Market Size and Forecast (2019-2030)
6.3.3 Canada Paediatric Vaccine Market Size and Forecast (2019-2030)
6.3.4 Mexico Paediatric Vaccine Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Paediatric Vaccine Consumption Value by Type (2019-2030)
7.2 Europe Paediatric Vaccine Consumption Value by Application (2019-2030)
7.3 Europe Paediatric Vaccine Market Size by Country
7.3.1 Europe Paediatric Vaccine Consumption Value by Country (2019-2030)
7.3.2 Germany Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.3 France Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.5 Russia Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.6 Italy Paediatric Vaccine Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Paediatric Vaccine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Paediatric Vaccine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Paediatric Vaccine Market Size by Region
8.3.1 Asia-Pacific Paediatric Vaccine Consumption Value by Region (2019-2030)
8.3.2 China Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.3 Japan Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.4 South Korea Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.5 India Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.7 Australia Paediatric Vaccine Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Paediatric Vaccine Consumption Value by Type (2019-2030)
9.2 South America Paediatric Vaccine Consumption Value by Application (2019-2030)
9.3 South America Paediatric Vaccine Market Size by Country
9.3.1 South America Paediatric Vaccine Consumption Value by Country (2019-2030)
9.3.2 Brazil Paediatric Vaccine Market Size and Forecast (2019-2030)
9.3.3 Argentina Paediatric Vaccine Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Paediatric Vaccine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Paediatric Vaccine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Paediatric Vaccine Market Size by Country
10.3.1 Middle East & Africa Paediatric Vaccine Consumption Value by Country (2019-2030)
10.3.2 Turkey Paediatric Vaccine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Paediatric Vaccine Market Size and Forecast (2019-2030)
10.3.4 UAE Paediatric Vaccine Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Paediatric Vaccine Market Drivers
11.2 Paediatric Vaccine Market Restraints
11.3 Paediatric Vaccine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Paediatric Vaccine Industry Chain
12.2 Paediatric Vaccine Upstream Analysis
12.3 Paediatric Vaccine Midstream Analysis
12.4 Paediatric Vaccine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Paediatric Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Paediatric Vaccine by Type
1.3.1 Overview: Global Paediatric Vaccine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Paediatric Vaccine Consumption Value Market Share by Type in 2023
1.3.3 Pneumococcal
1.3.4 Varicella
1.3.5 Combinations
1.3.6 Poliovirus
1.3.7 Hepatitis
1.3.8 MMR
1.3.9 Pediatric Hormones
1.3.10 HIB
1.3.11 Allergy and Respiratory vaccines
1.3.12 Other Pediatric vaccines
1.4 Global Paediatric Vaccine Market by Application
1.4.1 Overview: Global Paediatric Vaccine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age (0-3)
1.4.3 Age (3-12)
1.4.4 Age Above
1.5 Global Paediatric Vaccine Market Size & Forecast
1.6 Global Paediatric Vaccine Market Size and Forecast by Region
1.6.1 Global Paediatric Vaccine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Paediatric Vaccine Market Size by Region, (2019-2030)
1.6.3 North America Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.4 Europe Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.6 South America Paediatric Vaccine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Paediatric Vaccine Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 GlaxoSmithCline
2.1.1 GlaxoSmithCline Details
2.1.2 GlaxoSmithCline Major Business
2.1.3 GlaxoSmithCline Paediatric Vaccine Product and Solutions
2.1.4 GlaxoSmithCline Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithCline Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Paediatric Vaccine Product and Solutions
2.2.4 Merck Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Paediatric Vaccine Product and Solutions
2.3.4 Sanofi Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Paediatric Vaccine Product and Solutions
2.4.4 Bristol-Myers Squibb Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Paediatric Vaccine Product and Solutions
2.5.4 Abbott Laboratories Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Abbott Laboratories Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Paediatric Vaccine Product and Solutions
2.6.4 Eli Lilly Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Paediatric Vaccine Product and Solutions
2.7.4 Pfizer Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business
2.8.3 F. Hoffmann-La Roche Paediatric Vaccine Product and Solutions
2.8.4 F. Hoffmann-La Roche Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Paediatric Vaccine Product and Solutions
2.9.4 Novo Nordisk Paediatric Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novo Nordisk Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Paediatric Vaccine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Paediatric Vaccine by Company Revenue
3.2.2 Top 3 Paediatric Vaccine Players Market Share in 2023
3.2.3 Top 6 Paediatric Vaccine Players Market Share in 2023
3.3 Paediatric Vaccine Market: Overall Company Footprint Analysis
3.3.1 Paediatric Vaccine Market: Region Footprint
3.3.2 Paediatric Vaccine Market: Company Product Type Footprint
3.3.3 Paediatric Vaccine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Paediatric Vaccine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Paediatric Vaccine Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Paediatric Vaccine Consumption Value Market Share by Application (2019-2024)
5.2 Global Paediatric Vaccine Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Paediatric Vaccine Consumption Value by Type (2019-2030)
6.2 North America Paediatric Vaccine Consumption Value by Application (2019-2030)
6.3 North America Paediatric Vaccine Market Size by Country
6.3.1 North America Paediatric Vaccine Consumption Value by Country (2019-2030)
6.3.2 United States Paediatric Vaccine Market Size and Forecast (2019-2030)
6.3.3 Canada Paediatric Vaccine Market Size and Forecast (2019-2030)
6.3.4 Mexico Paediatric Vaccine Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Paediatric Vaccine Consumption Value by Type (2019-2030)
7.2 Europe Paediatric Vaccine Consumption Value by Application (2019-2030)
7.3 Europe Paediatric Vaccine Market Size by Country
7.3.1 Europe Paediatric Vaccine Consumption Value by Country (2019-2030)
7.3.2 Germany Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.3 France Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.5 Russia Paediatric Vaccine Market Size and Forecast (2019-2030)
7.3.6 Italy Paediatric Vaccine Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Paediatric Vaccine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Paediatric Vaccine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Paediatric Vaccine Market Size by Region
8.3.1 Asia-Pacific Paediatric Vaccine Consumption Value by Region (2019-2030)
8.3.2 China Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.3 Japan Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.4 South Korea Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.5 India Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Paediatric Vaccine Market Size and Forecast (2019-2030)
8.3.7 Australia Paediatric Vaccine Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Paediatric Vaccine Consumption Value by Type (2019-2030)
9.2 South America Paediatric Vaccine Consumption Value by Application (2019-2030)
9.3 South America Paediatric Vaccine Market Size by Country
9.3.1 South America Paediatric Vaccine Consumption Value by Country (2019-2030)
9.3.2 Brazil Paediatric Vaccine Market Size and Forecast (2019-2030)
9.3.3 Argentina Paediatric Vaccine Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Paediatric Vaccine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Paediatric Vaccine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Paediatric Vaccine Market Size by Country
10.3.1 Middle East & Africa Paediatric Vaccine Consumption Value by Country (2019-2030)
10.3.2 Turkey Paediatric Vaccine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Paediatric Vaccine Market Size and Forecast (2019-2030)
10.3.4 UAE Paediatric Vaccine Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Paediatric Vaccine Market Drivers
11.2 Paediatric Vaccine Market Restraints
11.3 Paediatric Vaccine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Paediatric Vaccine Industry Chain
12.2 Paediatric Vaccine Upstream Analysis
12.3 Paediatric Vaccine Midstream Analysis
12.4 Paediatric Vaccine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Paediatric Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Paediatric Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Paediatric Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Paediatric Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GlaxoSmithCline Company Information, Head Office, and Major Competitors
Table 6. GlaxoSmithCline Major Business
Table 7. GlaxoSmithCline Paediatric Vaccine Product and Solutions
Table 8. GlaxoSmithCline Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GlaxoSmithCline Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Paediatric Vaccine Product and Solutions
Table 13. Merck Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Paediatric Vaccine Product and Solutions
Table 18. Sanofi Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sanofi Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb Paediatric Vaccine Product and Solutions
Table 23. Bristol-Myers Squibb Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 26. Abbott Laboratories Major Business
Table 27. Abbott Laboratories Paediatric Vaccine Product and Solutions
Table 28. Abbott Laboratories Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Abbott Laboratories Recent Developments and Future Plans
Table 30. Eli Lilly Company Information, Head Office, and Major Competitors
Table 31. Eli Lilly Major Business
Table 32. Eli Lilly Paediatric Vaccine Product and Solutions
Table 33. Eli Lilly Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Eli Lilly Recent Developments and Future Plans
Table 35. Pfizer Company Information, Head Office, and Major Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Paediatric Vaccine Product and Solutions
Table 38. Pfizer Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Pfizer Recent Developments and Future Plans
Table 40. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 41. F. Hoffmann-La Roche Major Business
Table 42. F. Hoffmann-La Roche Paediatric Vaccine Product and Solutions
Table 43. F. Hoffmann-La Roche Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 45. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 46. Novo Nordisk Major Business
Table 47. Novo Nordisk Paediatric Vaccine Product and Solutions
Table 48. Novo Nordisk Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Novo Nordisk Recent Developments and Future Plans
Table 50. Global Paediatric Vaccine Revenue (USD Million) by Players (2019-2024)
Table 51. Global Paediatric Vaccine Revenue Share by Players (2019-2024)
Table 52. Breakdown of Paediatric Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Paediatric Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Paediatric Vaccine Players
Table 55. Paediatric Vaccine Market: Company Product Type Footprint
Table 56. Paediatric Vaccine Market: Company Product Application Footprint
Table 57. Paediatric Vaccine New Market Entrants and Barriers to Market Entry
Table 58. Paediatric Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Paediatric Vaccine Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Paediatric Vaccine Consumption Value Share by Type (2019-2024)
Table 61. Global Paediatric Vaccine Consumption Value Forecast by Type (2025-2030)
Table 62. Global Paediatric Vaccine Consumption Value by Application (2019-2024)
Table 63. Global Paediatric Vaccine Consumption Value Forecast by Application (2025-2030)
Table 64. North America Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Paediatric Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Paediatric Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Paediatric Vaccine Raw Material
Table 95. Key Suppliers of Paediatric Vaccine Raw Materials
Table 1. Global Paediatric Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Paediatric Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Paediatric Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Paediatric Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GlaxoSmithCline Company Information, Head Office, and Major Competitors
Table 6. GlaxoSmithCline Major Business
Table 7. GlaxoSmithCline Paediatric Vaccine Product and Solutions
Table 8. GlaxoSmithCline Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GlaxoSmithCline Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Paediatric Vaccine Product and Solutions
Table 13. Merck Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Paediatric Vaccine Product and Solutions
Table 18. Sanofi Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sanofi Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb Paediatric Vaccine Product and Solutions
Table 23. Bristol-Myers Squibb Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 26. Abbott Laboratories Major Business
Table 27. Abbott Laboratories Paediatric Vaccine Product and Solutions
Table 28. Abbott Laboratories Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Abbott Laboratories Recent Developments and Future Plans
Table 30. Eli Lilly Company Information, Head Office, and Major Competitors
Table 31. Eli Lilly Major Business
Table 32. Eli Lilly Paediatric Vaccine Product and Solutions
Table 33. Eli Lilly Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Eli Lilly Recent Developments and Future Plans
Table 35. Pfizer Company Information, Head Office, and Major Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Paediatric Vaccine Product and Solutions
Table 38. Pfizer Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Pfizer Recent Developments and Future Plans
Table 40. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 41. F. Hoffmann-La Roche Major Business
Table 42. F. Hoffmann-La Roche Paediatric Vaccine Product and Solutions
Table 43. F. Hoffmann-La Roche Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 45. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 46. Novo Nordisk Major Business
Table 47. Novo Nordisk Paediatric Vaccine Product and Solutions
Table 48. Novo Nordisk Paediatric Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Novo Nordisk Recent Developments and Future Plans
Table 50. Global Paediatric Vaccine Revenue (USD Million) by Players (2019-2024)
Table 51. Global Paediatric Vaccine Revenue Share by Players (2019-2024)
Table 52. Breakdown of Paediatric Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Paediatric Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Paediatric Vaccine Players
Table 55. Paediatric Vaccine Market: Company Product Type Footprint
Table 56. Paediatric Vaccine Market: Company Product Application Footprint
Table 57. Paediatric Vaccine New Market Entrants and Barriers to Market Entry
Table 58. Paediatric Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Paediatric Vaccine Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Paediatric Vaccine Consumption Value Share by Type (2019-2024)
Table 61. Global Paediatric Vaccine Consumption Value Forecast by Type (2025-2030)
Table 62. Global Paediatric Vaccine Consumption Value by Application (2019-2024)
Table 63. Global Paediatric Vaccine Consumption Value Forecast by Application (2025-2030)
Table 64. North America Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Paediatric Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Paediatric Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Paediatric Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Paediatric Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Paediatric Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Paediatric Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Paediatric Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Paediatric Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Paediatric Vaccine Raw Material
Table 95. Key Suppliers of Paediatric Vaccine Raw Materials
LIST OF FIGURES
Figure 1. Paediatric Vaccine Picture
Figure 2. Global Paediatric Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Paediatric Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Pneumococcal
Figure 5. Varicella
Figure 6. Combinations
Figure 7. Poliovirus
Figure 8. Hepatitis
Figure 9. MMR
Figure 10. Pediatric Hormones
Figure 11. HIB
Figure 12. Allergy and Respiratory vaccines
Figure 13. Other Pediatric vaccines
Figure 14. Global Paediatric Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 15. Paediatric Vaccine Consumption Value Market Share by Application in 2023
Figure 16. Age (0-3) Picture
Figure 17. Age (3-12) Picture
Figure 18. Age Above 12 Picture
Figure 19. Global Paediatric Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Paediatric Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Market Paediatric Vaccine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 22. Global Paediatric Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. Global Paediatric Vaccine Consumption Value Market Share by Region in 2023
Figure 24. North America Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East and Africa Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Paediatric Vaccine Revenue Share by Players in 2023
Figure 30. Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 31. Global Top 3 Players Paediatric Vaccine Market Share in 2023
Figure 32. Global Top 6 Players Paediatric Vaccine Market Share in 2023
Figure 33. Global Paediatric Vaccine Consumption Value Share by Type (2019-2024)
Figure 34. Global Paediatric Vaccine Market Share Forecast by Type (2025-2030)
Figure 35. Global Paediatric Vaccine Consumption Value Share by Application (2019-2024)
Figure 36. Global Paediatric Vaccine Market Share Forecast by Application (2025-2030)
Figure 37. North America Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 38. North America Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 39. North America Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 44. Europe Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 45. Europe Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 47. France Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Paediatric Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 57. India Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 61. South America Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 62. South America Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East and Africa Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 66. Middle East and Africa Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 67. Middle East and Africa Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 69. Saudi Arabia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 70. UAE Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 71. Paediatric Vaccine Market Drivers
Figure 72. Paediatric Vaccine Market Restraints
Figure 73. Paediatric Vaccine Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Manufacturing Cost Structure Analysis of Paediatric Vaccine in 2023
Figure 76. Manufacturing Process Analysis of Paediatric Vaccine
Figure 77. Paediatric Vaccine Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
Figure 1. Paediatric Vaccine Picture
Figure 2. Global Paediatric Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Paediatric Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Pneumococcal
Figure 5. Varicella
Figure 6. Combinations
Figure 7. Poliovirus
Figure 8. Hepatitis
Figure 9. MMR
Figure 10. Pediatric Hormones
Figure 11. HIB
Figure 12. Allergy and Respiratory vaccines
Figure 13. Other Pediatric vaccines
Figure 14. Global Paediatric Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 15. Paediatric Vaccine Consumption Value Market Share by Application in 2023
Figure 16. Age (0-3) Picture
Figure 17. Age (3-12) Picture
Figure 18. Age Above 12 Picture
Figure 19. Global Paediatric Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Paediatric Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Market Paediatric Vaccine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 22. Global Paediatric Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. Global Paediatric Vaccine Consumption Value Market Share by Region in 2023
Figure 24. North America Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East and Africa Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Paediatric Vaccine Revenue Share by Players in 2023
Figure 30. Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 31. Global Top 3 Players Paediatric Vaccine Market Share in 2023
Figure 32. Global Top 6 Players Paediatric Vaccine Market Share in 2023
Figure 33. Global Paediatric Vaccine Consumption Value Share by Type (2019-2024)
Figure 34. Global Paediatric Vaccine Market Share Forecast by Type (2025-2030)
Figure 35. Global Paediatric Vaccine Consumption Value Share by Application (2019-2024)
Figure 36. Global Paediatric Vaccine Market Share Forecast by Application (2025-2030)
Figure 37. North America Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 38. North America Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 39. North America Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 44. Europe Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 45. Europe Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 47. France Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Paediatric Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 57. India Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 61. South America Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 62. South America Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East and Africa Paediatric Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 66. Middle East and Africa Paediatric Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 67. Middle East and Africa Paediatric Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 69. Saudi Arabia Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 70. UAE Paediatric Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 71. Paediatric Vaccine Market Drivers
Figure 72. Paediatric Vaccine Market Restraints
Figure 73. Paediatric Vaccine Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Manufacturing Cost Structure Analysis of Paediatric Vaccine in 2023
Figure 76. Manufacturing Process Analysis of Paediatric Vaccine
Figure 77. Paediatric Vaccine Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
